24 results
425
EX-2.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
to have, individually or in the aggregate, a Company Material Adverse Effect.
(g) Privacy and Data Security. The Company has complied with all applicable … , transfer, or protection of personal information or actual, alleged, or suspected violation of any applicable Law concerning privacy, data security
8-K
EX-2.1
THER
Theralink Technologies, Inc.
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
to have, individually or in the aggregate, a Company Material Adverse Effect.
(g) Privacy and Data Security. The Company has complied with all applicable … , transfer, or protection of personal information or actual, alleged, or suspected violation of any applicable Law concerning privacy, data security
DEFM14C
dmar0mi203ca5
31 Aug 20
Information related to merger
7:00am
PREM14C
k21ijcnl
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
t2znvg
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-2.1
wjex2wbkhxv8150ifbgh
13 May 20
Entry into a Material Definitive Agreement
5:10pm
8-K/A
EX-10.2
po83 tf6yz1jnfy61
21 Feb 19
Financial Statements and Exhibits
5:14pm